These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 28212564)
21. Tim-3 expression in cervical cancer promotes tumor metastasis. Cao Y; Zhou X; Huang X; Li Q; Gao L; Jiang L; Huang M; Zhou J PLoS One; 2013; 8(1):e53834. PubMed ID: 23335978 [TBL] [Abstract][Full Text] [Related]
22. Elevated Expression of Kin17 in Cervical Cancer and Its Association With Cancer Cell Proliferation and Invasion. Zhang Y; Gao H; Gao X; Huang S; Wu K; Yu X; Yuan K; Zeng T Int J Gynecol Cancer; 2017 May; 27(4):628-633. PubMed ID: 28346239 [TBL] [Abstract][Full Text] [Related]
23. OLFM4 Inhibits Epithelial-Mesenchymal Transition and Metastatic Potential of Cervical Cancer Cells. Li J; Liu C; Li D; Wan M; Zhang H; Zheng X; Jie X; Zhang P; Li J; Hou H; Sun Q Oncol Res; 2019 Jul; 27(7):763-771. PubMed ID: 30764901 [TBL] [Abstract][Full Text] [Related]
24. Sex-determining region Y-related high mobility group box (SOX)-2 is overexpressed in cervical squamous cell carcinoma and contributes cervical cancer cell migration and invasion in vitro. Chang X; Zhang J; Huang C; Pang X; Luo Q; Zhang H; Zhang S Tumour Biol; 2015 Sep; 36(10):7725-33. PubMed ID: 25935536 [TBL] [Abstract][Full Text] [Related]
25. Epidermal growth factor receptor kinase substrate 8 promotes the metastasis of cervical cancer via the epithelial-mesenchymal transition. Li Q; Bao W; Fan Q; Shi WJ; Li ZN; Xu Y; Wu D Mol Med Rep; 2016 Oct; 14(4):3220-8. PubMed ID: 27573546 [TBL] [Abstract][Full Text] [Related]
26. CRIP1 promotes cell migration, invasion and epithelial-mesenchymal transition of cervical cancer by activating the Wnt/β‑catenin signaling pathway. Zhang LZ; Huang LY; Huang AL; Liu JX; Yang F Life Sci; 2018 Aug; 207():420-427. PubMed ID: 29959029 [TBL] [Abstract][Full Text] [Related]
27. XPNPEP2 is overexpressed in cervical cancer and promotes cervical cancer metastasis. Cheng T; Wei R; Jiang G; Zhou Y; Lv M; Dai Y; Yuan Y; Luo D; Ma D; Li F; Xi L Tumour Biol; 2017 Jul; 39(7):1010428317717122. PubMed ID: 28670957 [TBL] [Abstract][Full Text] [Related]
28. Inhibiting the redox function of APE1 suppresses cervical cancer metastasis via disengagement of ZEB1 from E-cadherin in EMT. Li Q; Zhou ZW; Duan W; Qian CY; Wang SN; Deng MS; Zi D; Wang JM; Mao CY; Song G; Wang D; Westover KD; Xu CX J Exp Clin Cancer Res; 2021 Jul; 40(1):220. PubMed ID: 34210327 [TBL] [Abstract][Full Text] [Related]
29. REX1 promotes EMT-induced cell metastasis by activating the JAK2/STAT3-signaling pathway by targeting SOCS1 in cervical cancer. Zeng YT; Liu XF; Yang WT; Zheng PS Oncogene; 2019 Oct; 38(43):6940-6957. PubMed ID: 31409905 [TBL] [Abstract][Full Text] [Related]
30. Placenta growth factor promotes migration through regulating epithelial-mesenchymal transition-related protein expression in cervical cancer. Huang W; Zhu S; Liu Q; Li C; Li L Int J Clin Exp Pathol; 2014; 7(12):8506-19. PubMed ID: 25674215 [TBL] [Abstract][Full Text] [Related]
31. Correlation of TWIST2 up-regulation and epithelial-mesenchymal transition during tumorigenesis and progression of cervical carcinoma. Li Y; Wang W; Wang W; Yang R; Wang T; Su T; Weng D; Tao T; Li W; Ma D; Wang S Gynecol Oncol; 2012 Jan; 124(1):112-8. PubMed ID: 22018873 [TBL] [Abstract][Full Text] [Related]
32. Tripartite motif containing 62 is a novel prognostic marker and suppresses tumor metastasis via c-Jun/Slug signaling-mediated epithelial-mesenchymal transition in cervical cancer. Liu TY; Chen J; Shang CL; Shen HW; Huang JM; Liang YC; Wang W; Zhao YH; Liu D; Shu M; Guo LY; Hu Z; Yao SZ J Exp Clin Cancer Res; 2016 Oct; 35(1):170. PubMed ID: 27793172 [TBL] [Abstract][Full Text] [Related]
33. Sulfiredoxin may promote metastasis and invasion of cervical squamous cell carcinoma by epithelial-mesenchymal transition. Chen X; Lan K; Liu Q; Yang X; Wang H Tumour Biol; 2017 Mar; 39(3):1010428317695942. PubMed ID: 28351308 [TBL] [Abstract][Full Text] [Related]
34. Down-regulation of Frizzled-7 expression inhibits migration, invasion, and epithelial-mesenchymal transition of cervical cancer cell lines. Deng B; Zhang S; Miao Y; Zhang Y; Wen F; Guo K Med Oncol; 2015 Apr; 32(4):102. PubMed ID: 25740178 [TBL] [Abstract][Full Text] [Related]
35. ΔNp63α attenuates tumor aggressiveness by suppressing miR-205/ZEB1-mediated epithelial-mesenchymal transition in cervical squamous cell carcinoma. Zhao W; Wang H; Han X; Ma J; Zhou Y; Chen Z; Zhou H; Xu H; Sun Z; Kong B; Fang H Tumour Biol; 2016 Aug; 37(8):10621-32. PubMed ID: 26864590 [TBL] [Abstract][Full Text] [Related]
36. JAM3 promotes cervical cancer metastasis by activating the HIF-1α/VEGFA pathway. Peng J; Chen Y; Yin A BMC Womens Health; 2024 May; 24(1):293. PubMed ID: 38760803 [TBL] [Abstract][Full Text] [Related]
37. Programmed death ligand 1 promotes lymph node metastasis and glucose metabolism in cervical cancer by activating integrin β4/SNAI1/SIRT3 signaling pathway. Wang S; Li J; Xie J; Liu F; Duan Y; Wu Y; Huang S; He X; Wang Z; Wu X Oncogene; 2018 Jul; 37(30):4164-4180. PubMed ID: 29706653 [TBL] [Abstract][Full Text] [Related]
38. The TGFβ-induced lncRNA TBILA promotes non-small cell lung cancer progression in vitro and in vivo via cis-regulating HGAL and activating S100A7/JAB1 signaling. Lu Z; Li Y; Che Y; Huang J; Sun S; Mao S; Lei Y; Li N; Sun N; He J Cancer Lett; 2018 Sep; 432():156-168. PubMed ID: 29908210 [TBL] [Abstract][Full Text] [Related]
39. Roles of immune inhibitory molecule B7-H4 in cervical cancer. Han S; Li Y; Zhang J; Liu L; Chen Q; Qian Q; Li S; Zhang Y Oncol Rep; 2017 Apr; 37(4):2308-2316. PubMed ID: 28260085 [TBL] [Abstract][Full Text] [Related]
40. MiR-223 inhibited cell metastasis of human cervical cancer by modulating epithelial-mesenchymal transition. Tang Y; Wang Y; Chen Q; Qiu N; Zhao Y; You X Int J Clin Exp Pathol; 2015; 8(9):11224-9. PubMed ID: 26617846 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]